A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma

Brent Siesky, Alon Harris, Daniel Sines, Ehud Rechtman, Victor E. Malinovsky, Lynne McCranor, Chi Wah Yung, Miriam Zalish

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aims: The aim of this study was to assess the effects of fixed combination of timolol and dorzolamide and latanoprost plus timolol on retinal, choroidal, and retrobulbar hemodynamics and visual function in primary open-angle glaucoma (OAG) subjects. Methods: Sixteen (16) OAG patients (age, 63.5 ± 10.8 years; 9 male) were evaluated in a randomized, crossover, double-blind study design after 4 weeks of treatment of latanoprost with timolol and fixed combination of timolol and dorzolamide. After randomization, 9 right eyes and 7 left eyes were included in the hemodynamic portion of the study. Measurements included: adverse events check, visual acuity, contrast sensitivity, blood pressure, heart rate, intraocular pressure (IOP), and fundus examination. Ocular blood flow was assessed using confocal scanning laser Doppler flowmetry, color Doppler imaging, and scanning laser ophthalmoscopy. Results: Both therapies were effective at lowering IOP, whereas there was no statistically significant difference between Iatanoprost plus timolol and the fixed combination of timolol and dorzolamide (13.9% and 12.2% reduction, respectively; P = 0.5533). Fixed combination of timolol and dorzolamide significantly increased central retinal artery end diastolic blood flow velocity (P = 0.0168) and lowered resistance to flow (P = 0.0279). Temporal posterior ciliary artery peak systolic and end diastolic velocities were significantly increased with the fixed combination of timolol and dorzolamide (P = 0.0125 and 0.0238, respectively). Latanoprost plus timolol had no significant effects on ocular blood flow during 4 weeks of treatment. There were no statistically significant differences in adverse events, blood pressure, heart rate, visual acuity, contrast sensitivity scanning laser ophthalmoscopy, or Heidelberg Retinal Flowmeter for any treatment period. Conclusions: Fixed combination of timolol and dorzolamide therapy might increase blood flow in OAG patients while attaining a similar IOP reduction compared to Iatanoprost plus timolol. Visual function, however, was not different in this short-term comparison between the two treatments.

Original languageEnglish
Pages (from-to)353-361
Number of pages9
JournalJournal of Ocular Pharmacology and Therapeutics
Volume22
Issue number5
DOIs
StatePublished - Oct 2006

Fingerprint

latanoprost
Timolol
Hemodynamics
Intraocular Pressure
Ophthalmoscopy
Contrast Sensitivity
Open Angle Glaucoma
Visual Acuity
Lasers
Therapeutics
Heart Rate
Ciliary Arteries
Blood Pressure
Retinal Artery
Flowmeters
Laser-Doppler Flowmetry
Blood Flow Velocity
Random Allocation
Double-Blind Method
Primary Open Angle Glaucoma

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Ophthalmology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma. / Siesky, Brent; Harris, Alon; Sines, Daniel; Rechtman, Ehud; Malinovsky, Victor E.; McCranor, Lynne; Yung, Chi Wah; Zalish, Miriam.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 22, No. 5, 10.2006, p. 353-361.

Research output: Contribution to journalArticle

@article{70603a5a6e0d4eb99ef40483740853e0,
title = "A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma",
abstract = "Aims: The aim of this study was to assess the effects of fixed combination of timolol and dorzolamide and latanoprost plus timolol on retinal, choroidal, and retrobulbar hemodynamics and visual function in primary open-angle glaucoma (OAG) subjects. Methods: Sixteen (16) OAG patients (age, 63.5 ± 10.8 years; 9 male) were evaluated in a randomized, crossover, double-blind study design after 4 weeks of treatment of latanoprost with timolol and fixed combination of timolol and dorzolamide. After randomization, 9 right eyes and 7 left eyes were included in the hemodynamic portion of the study. Measurements included: adverse events check, visual acuity, contrast sensitivity, blood pressure, heart rate, intraocular pressure (IOP), and fundus examination. Ocular blood flow was assessed using confocal scanning laser Doppler flowmetry, color Doppler imaging, and scanning laser ophthalmoscopy. Results: Both therapies were effective at lowering IOP, whereas there was no statistically significant difference between Iatanoprost plus timolol and the fixed combination of timolol and dorzolamide (13.9{\%} and 12.2{\%} reduction, respectively; P = 0.5533). Fixed combination of timolol and dorzolamide significantly increased central retinal artery end diastolic blood flow velocity (P = 0.0168) and lowered resistance to flow (P = 0.0279). Temporal posterior ciliary artery peak systolic and end diastolic velocities were significantly increased with the fixed combination of timolol and dorzolamide (P = 0.0125 and 0.0238, respectively). Latanoprost plus timolol had no significant effects on ocular blood flow during 4 weeks of treatment. There were no statistically significant differences in adverse events, blood pressure, heart rate, visual acuity, contrast sensitivity scanning laser ophthalmoscopy, or Heidelberg Retinal Flowmeter for any treatment period. Conclusions: Fixed combination of timolol and dorzolamide therapy might increase blood flow in OAG patients while attaining a similar IOP reduction compared to Iatanoprost plus timolol. Visual function, however, was not different in this short-term comparison between the two treatments.",
author = "Brent Siesky and Alon Harris and Daniel Sines and Ehud Rechtman and Malinovsky, {Victor E.} and Lynne McCranor and Yung, {Chi Wah} and Miriam Zalish",
year = "2006",
month = "10",
doi = "10.1089/jop.2006.22.353",
language = "English",
volume = "22",
pages = "353--361",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma

AU - Siesky, Brent

AU - Harris, Alon

AU - Sines, Daniel

AU - Rechtman, Ehud

AU - Malinovsky, Victor E.

AU - McCranor, Lynne

AU - Yung, Chi Wah

AU - Zalish, Miriam

PY - 2006/10

Y1 - 2006/10

N2 - Aims: The aim of this study was to assess the effects of fixed combination of timolol and dorzolamide and latanoprost plus timolol on retinal, choroidal, and retrobulbar hemodynamics and visual function in primary open-angle glaucoma (OAG) subjects. Methods: Sixteen (16) OAG patients (age, 63.5 ± 10.8 years; 9 male) were evaluated in a randomized, crossover, double-blind study design after 4 weeks of treatment of latanoprost with timolol and fixed combination of timolol and dorzolamide. After randomization, 9 right eyes and 7 left eyes were included in the hemodynamic portion of the study. Measurements included: adverse events check, visual acuity, contrast sensitivity, blood pressure, heart rate, intraocular pressure (IOP), and fundus examination. Ocular blood flow was assessed using confocal scanning laser Doppler flowmetry, color Doppler imaging, and scanning laser ophthalmoscopy. Results: Both therapies were effective at lowering IOP, whereas there was no statistically significant difference between Iatanoprost plus timolol and the fixed combination of timolol and dorzolamide (13.9% and 12.2% reduction, respectively; P = 0.5533). Fixed combination of timolol and dorzolamide significantly increased central retinal artery end diastolic blood flow velocity (P = 0.0168) and lowered resistance to flow (P = 0.0279). Temporal posterior ciliary artery peak systolic and end diastolic velocities were significantly increased with the fixed combination of timolol and dorzolamide (P = 0.0125 and 0.0238, respectively). Latanoprost plus timolol had no significant effects on ocular blood flow during 4 weeks of treatment. There were no statistically significant differences in adverse events, blood pressure, heart rate, visual acuity, contrast sensitivity scanning laser ophthalmoscopy, or Heidelberg Retinal Flowmeter for any treatment period. Conclusions: Fixed combination of timolol and dorzolamide therapy might increase blood flow in OAG patients while attaining a similar IOP reduction compared to Iatanoprost plus timolol. Visual function, however, was not different in this short-term comparison between the two treatments.

AB - Aims: The aim of this study was to assess the effects of fixed combination of timolol and dorzolamide and latanoprost plus timolol on retinal, choroidal, and retrobulbar hemodynamics and visual function in primary open-angle glaucoma (OAG) subjects. Methods: Sixteen (16) OAG patients (age, 63.5 ± 10.8 years; 9 male) were evaluated in a randomized, crossover, double-blind study design after 4 weeks of treatment of latanoprost with timolol and fixed combination of timolol and dorzolamide. After randomization, 9 right eyes and 7 left eyes were included in the hemodynamic portion of the study. Measurements included: adverse events check, visual acuity, contrast sensitivity, blood pressure, heart rate, intraocular pressure (IOP), and fundus examination. Ocular blood flow was assessed using confocal scanning laser Doppler flowmetry, color Doppler imaging, and scanning laser ophthalmoscopy. Results: Both therapies were effective at lowering IOP, whereas there was no statistically significant difference between Iatanoprost plus timolol and the fixed combination of timolol and dorzolamide (13.9% and 12.2% reduction, respectively; P = 0.5533). Fixed combination of timolol and dorzolamide significantly increased central retinal artery end diastolic blood flow velocity (P = 0.0168) and lowered resistance to flow (P = 0.0279). Temporal posterior ciliary artery peak systolic and end diastolic velocities were significantly increased with the fixed combination of timolol and dorzolamide (P = 0.0125 and 0.0238, respectively). Latanoprost plus timolol had no significant effects on ocular blood flow during 4 weeks of treatment. There were no statistically significant differences in adverse events, blood pressure, heart rate, visual acuity, contrast sensitivity scanning laser ophthalmoscopy, or Heidelberg Retinal Flowmeter for any treatment period. Conclusions: Fixed combination of timolol and dorzolamide therapy might increase blood flow in OAG patients while attaining a similar IOP reduction compared to Iatanoprost plus timolol. Visual function, however, was not different in this short-term comparison between the two treatments.

UR - http://www.scopus.com/inward/record.url?scp=33750717258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750717258&partnerID=8YFLogxK

U2 - 10.1089/jop.2006.22.353

DO - 10.1089/jop.2006.22.353

M3 - Article

C2 - 17076630

AN - SCOPUS:33750717258

VL - 22

SP - 353

EP - 361

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 5

ER -